-
Jim James of My Morning Jacket and Jeff Tweedy of Wilco are two artists who've dipped their toes into the Grateful Dead extended universe through a singular experience: by sharing the stage with Bob Weir. -
Mario Tama/Getty ImagesWisconsin Democratic candidate for governor Francesca Hong called for a moratorium on data centers. So did Ohio Republican governor hopeful Vivek Ramaswamy, as data centers begin to dominate campaigns.
-
The Senate narrowly confirmed Todd Blanche as U.S. attorney general early Saturday morning, elevating President Trump's former personal lawyer to head the Justice Department. -
Trump is once again threatening to fire Cook over unproven allegations of mortgage fraud after an earlier effort to remove Cook was struck down by the Supreme Court. -
A federal appeals court says above-ground construction cannot continue without approval from Congress, siding with historic preservation advocates. -
The bill is meant to stifle Russia's economy by allowing for tough new tariffs against major importers of Russian energy. The legislation was led by Lindsey Graham before his unexpected death in July.
John Vizcaino
/
AP
A new political era for Colombia: a hard-right president promises order, growth and confrontation.
Kevin Dietsch
/
Getty Images
Joe Raedle
/
Getty Images
-
The singer, who had a viral hit last year with "Sally, When the Wine Runs Out," filled his follow-up album, Chuck Timely & The Hourglass, with dive bar jukebox melodies and live instrumentation. -
Over 1 million people a year die from diarrheal disease. Nearly half are kids under age 5. A new vaccine in trials offers great hope. -
The internationally known chef, writer, and television star died in 2018. Tony, starring Dominic Sessa, tells just a splinter of Bourdain's life — the mid-1970s summer when he was 19. -
For years, doctors advised against hormone therapy for women in the menopausal transition. Now everyone's talking about how great it is. Is it really a wonder drug that women should all be on? -
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
